The dietary supplement Lipodrene faces a total ban in Mexico after an alert was issued by the Federal Commission for the Protection against Health Risks (Cofepris). This measure, announced on March 30, responds to the detection of hazardous ingredients and deceptive promotions that violate Mexican health regulations.
Prohibited ingredients and health threats
The Cofepris identified in the dietary supplement prohibited substances such as ephedrine, yohimbine, and 1,4-dimethylamylamine (DMAA). These components can raise blood pressure, constrict blood vessels, and cause severe cardiovascular problems. Additionally, Citrus aurantium and other extracts are listed in the Herbal Pharmacopeia as toxic. The lack of data on composition, interactions with medications, and production conditions aggravates the danger.
Presence of the dietary supplement in the Dominican Republic
In the Dominican Republic, this dietary supplement is sold freely on local digital platforms such as begyuga.com and lapulga.com.do. It is promoted to lose weight, control appetite, and increase energy, illegal claims according to the General Health Law of Mexico, which limits these products to complement the diet without therapeutic properties.
Strict regulation by Cofepris and international context
The Mexican authority, under the Sanitary Control Regulation of Products and Services, prohibits curative attributions in supplements. Penalties include fines of up to 16,000 UMA, closures, and forced removals. The FDA in the United States had already warned about Lipodrene due to DMAA in specific lots. Health experts emphasize that these products generate false expectations and risks without medical supervision.
Additional risks and recommendations
Other ingredients such as ginger, orange, and cayenne pepper complete a toxic profile not scientifically evaluated. Cofepris advises not to consume, buy, or distribute the dietary supplement Lipodrene, especially through apps or messaging. Reporting sales to authorities and consulting doctors in case of symptoms is key to avoiding fatal interactions.
- They do not guarantee safety or efficacy without evidence.
- They violate advertising and labeling norms (NOM-251-SSA1-2009).
- They are prohibited for children, pregnant women, and without a prescription.
In Mexico, recent reforms seek greater control over supplements, aligning with global standards that require scientific backing. For Dominicans, this alert from Cofepris highlights the urgency of verifying local regulations in the face of online sales of this dietary supplement. Consumers must prioritize reliable sources to protect their health in a borderless digital market.
